Table 1.
Groups | Initial body weight (g) | Body weight change (g) |
---|---|---|
Cnt | 20.25 ± 0.75 | 4.26 ± 0.33b |
Amy | 21.47 ± 0.67 | 2.75 ± 0.12c |
SorIP | 21.75 ± 0.85 | − 7.23 ± 0.41f |
SorOS | 20.75 ± 0.65 | − 8.28 ± 0.60f |
Amy + SorIP | 21.31 ± 0.71 | 2.25 ± 0.12c |
Amy + SorOS | 21.00 ± 0.40 | − 4.22 ± 0.45e |
EAC | 20.48 ± 0.63 | 7.53 ± 0.92a |
EAC + Amy | 21.63 ± 0.55 | 4.62 ± 0.46b |
EAC + SorIP | 21.26 ± 0.40 | − 3.75 ± 0.30e |
EAC + SorOS | 20.60 ± 0.85 | − 3.52 ± 0.31e |
EAC + Amy + SorIP | 21.50 ± 0.69 | − 0.24 ± 0.10d |
EAC + Amy + SorOS | 21.06 ± 0.41 | − 2.87 ± 0.12e |
Data were presented as means ± SEM. Small (a–f) letters showed the marked change at P ≤ 0.05. The significant were expressed by dissimilar letters in the same column. Cnt Control, Amy Amygdalin, Sor Sorafenib, EAC Ehrlich ascetic carcinoma, IP Intraperitoneal, OS Per os (oral).